|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C12N 15/62 | (2006.01) |
| A61K 38/17 | (2006.01) | ||
| A61K 47/48 | (2006.01) | ||
| C07K 14/47 | (2006.01) | ||
| C07K 14/71 | (2006.01) |
| (11) | Number of the document | 2092069 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07866627.8 |
| Date of filing the European patent application | 2007-11-28 | |
| (97) | Date of publication of the European application | 2009-08-26 |
| (45) | Date of publication and mention of the grant of the patent | 2011-05-11 |
| (46) | Date of publication of the claims translation | 2011-08-25 |
| (86) | Number | PCT/IB2007/004354 |
| Date | 2007-11-28 |
| (87) | Number | WO 2008/065543 |
| Date | 2008-06-05 |
| (30) | Number | Date | Country code |
| 06291824 | 2006-11-28 | EP | |
| 07290042 | 2007-01-11 | EP |
| (72) |
NESBIT, Mark, FR
CAMERON, Béatrice, FR
BLANCHE, Francis, FR
SORDELLO, Sylvie, FR
NICOLAZZI, Céline, FR
TROMBE, Marc, FR
|
| (73) |
Aventis Pharma S.A.,
20, avenue Raymond Aron, 92160 Antony,
FR
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Modifikuotos tirpaus FGF receptoriaus/Fc fuzijos su padidintu biologiniu aktyvumu |
| MODIFIED SOLUBLE FGF RECEPTOR FC FUSIONS WITH IMPROVED BIOLOGICAL ACTIVITY |
| Payment date | Validity (years) | Amount | |
| 2013-10-30 | 7 | 560.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2014-11-28 |